Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NEW USE OF INHIBITOR OF CYSTINE-GLUTAMATE TRANSPORTER
Document Type and Number:
WIPO Patent Application WO/2016/192687
Kind Code:
A1
Abstract:
The agents that inhibit system x c - provide the therapeutic intervention in substance-related and addictive disorders and the treatment and/or prevention in substance-mediated brain damage, and confirm that system x c -is a promising therapeutic target for substance-induced addiction and brain damage.

Inventors:
HSIEH CHIA-HUNG (CN)
Application Number:
PCT/CN2016/085002
Publication Date:
December 08, 2016
Filing Date:
June 06, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV CHINA MEDICAL (CN)
International Classes:
A61K31/44; A61K31/63; A61P25/32; A61P25/36
Domestic Patent References:
WO2007084541A22007-07-26
WO2015070034A12015-05-14
WO2014197536A22014-12-11
Other References:
TZSCHENTKE, T.M.W.J. SCHMIDT: "Glutamatergic mechanisms in addiction", MOL PSYCHIATRY, vol. 8, no. 4, 2003, pages 373 - 82
DING, Z.M. ET AL.: "Alcohol drinking and deprivation alter basal extracellular glutamate concentrations and clearance in the mesolimbic system of alcohol-preferring (P) rats", ADDICT BIOL, vol. 18, no. 2, 2013, pages 297 - 306
WILLIAMS, J.M., J.D. STEKETEE: "Steketee, Cocaine increases medial prefrontal cortical glutamate overflow in cocaine-sensitized rats: a time course study", EUR J NEUROSCI, vol. 20, no. 6, 2004, pages 1639 - 46
SAELLSTROEM BAUM, S. ET AL.: "Nicotine stimulation on extracellular glutamate levels in the nucleus accumbens of ethanol-withdrawn rats in vivo", ALCOHOL CLIN EXP RES, vol. 30, no. 8, 2006, pages 1414 - 21
MOGHADDAM, B. ET AL.: "Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex", J NEUROSCI, vol. 17, no. 8, 1997, pages 2921 - 7
DEL ARCO, A. ET AL.: "Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high affinity transporter mechanisms", NEUROPHARMACOLOGY, vol. 38, no. 7, 1999, pages 943 - 54
PETERS, J.T.J. DE VRIES: "Glutamate mechanisms underlying opiate memories", COLD SPRING HARB PERSPECT MED, vol. 2, no. 9, 2012, pages a012088
GONZALES, R.A.J.N. JAWORSKI: "Alcohol and glutamate", ALCOHOL HEALTH RES WORLD, vol. 21, no. 2, 1997, pages 120 - 7
BRIDGES, R.J.N.R. NATALES.A. PATEL: "System xc(-) cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS", BR JPHARMACOL, vol. 165, no. 1, 2012, pages 20 - 34, XP055247839, DOI: 10.1111/j.1476-5381.2011.01480.x
SATO, H. ET AL.: "Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins.", J BIOL CHEM, vol. 274, no. 17, 1999, pages 11455 - 8, XP002941607, DOI: 10.1074/jbc.274.17.11455
BUCKINGHAM, S.C. ET AL.: "Glutamate release by primary brain tumors induces epileptic activity", NAT MED, vol. 17, no. 10, 2011, pages 1269 - 74
ALBRECHT, P. ET AL.: "Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target", CNS NEUROL DISORD DRUG TARGETS, vol. 9, no. 3, 2010, pages 373 - 82
DE BUNDEL, D. ET AL.: "Loss of system x(c)- does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility", J NEUROSCI, vol. 31, no. 15, 2011, pages 5792 - 803
BAKER, D.A., ET AL.: "Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse", NAT NEUROSCI, vol. 6, no. 7, 2003, pages 743 - 9, XP008132286, DOI: 10.1038/nn1069
KNACKSTEDT, L.A., ET AL.: "The role of cystine-glutamate exchange in nicotine dependence in rats and humans", BIOL PSYCHIATRY, vol. 65, no. 10, 2009, pages 841 - 5, XP026056813, DOI: 10.1016/j.biopsych.2008.10.040
PEANA, A. T.G. MUGGIRONIF. BENNARDINI: "Change of cystine/glutamate antiporter expression in ethanol-dependent rats", FRONT NEUROSCI, vol. 8, 2014, pages 311
LEWERENZ, J. ET AL.: "The cystine/glutamate antiporter system x(c)(~) in health and disease: from molecular mechanisms to novel therapeutic opportunities", ANTIOXID REDOX SIGNAL, vol. 18, no. 5, 2013, pages 522 - 55, XP055592843, DOI: 10.1089/ars.2011.4391
BAKER ET AL., NATURE NEUROSCIENCE, vol. 6, no. 7, 2003, pages 743 - 749
PEANA ET AL., FRONTIERS IN NEUROSCIENCE, vol. 8, no. 311, 2014
PATEL ET AL., MOI. MEMBR. BIOL., vol. 32, no. 4, 2015, pages 89 - 116
SHYU, W.C., ET AL.: "Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke", J CLIN INVEST, vol. 118, no. 1, 2008, pages 133 - 48
CHUNG, W.J. ET AL.: "Inhibition of cystine uptake disrupts the growth of primary brain tumors", J NEUROSCI, vol. 25, no. 31, 2005, pages 7101 - 10
See also references of EP 3302493A4
Attorney, Agent or Firm:
LEE AND LI - LEAVEN IPR AGENCY LTD. (Tower A Beijing Marriott Center, No. 7,,Jian Guo Men South Avenue, Beijing 5, CN)
Download PDF: